Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Completed · Phase 2

Conditions studied: Melanoma

In brief

The purpose of this clinical research study is to compare the best overall response rate (BORR)(as per modified WHO criteria) in patients with previously treated, therapy-refractory, or -intolerant, Stage III (unresectable) or Stage IV melanoma receiving ipilimumab doses of 0.3, 3, and 10 mg/kg. The safety of this product will also be evaluated.

Key facts

Study ID

NCT00289640

Run by

Bristol-Myers Squibb

People needed

210

Starts

2006-04-01

Expected to finish

2007-07-01

Last updated by the study team

2010-03-02

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with previously treated, therapy-refractory or -intolerant, Stage III (unresectable) or Stage IV melanoma

Where it is running

• Wilshire Oncology Medical Group Inc — Laverne, California, United States
• Scripps Cancer Center — San Diego, California, United States
• The Angeles Clinic And Research Institution — Santa Monica, California, United States
• Yale University School Of Medicine — New Haven, Connecticut, United States
• Baptist Cancer Institute — Jacksonville, Florida, United States
• Mount Sinai Comprehensive Cancer Center — Miami Beach, Florida, United States
• Md Anderson Cancer Center Orlando — Orlando, Florida, United States
• Palm Beach Cancer Institute — West Palm Beach, Florida, United States
• Oncology Specialists, Sc — Park Ridge, Illinois, United States
• American Health Network — Indianapolis, Indiana, United States
• University Of Louisville — Louisville, Kentucky, United States
• Harry And Jeanette Weinberg Cancer Inst At Franklin Square — Baltimore, Maryland, United States
• Hubert H. Humphrey Cancer Center — Robbinsdale, Minnesota, United States
• Ellis Fischel Cancer Center — Columbia, Missouri, United States
• St Joseph Oncology Inc — Saint Joseph, Missouri, United States
• Washington University School Of Medicine — St Louis, Missouri, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States
• Presbyterian Hospital — Charlotte, North Carolina, United States
• The Christ Hospital Cancer Center Research — Cincinnati, Ohio, United States
• Cleveland Clinic — Cleveland, Ohio, United States
• Providence Portland Medical Center — Portland, Oregon, United States
• Cancer Centers Of The Carolinas — Greenville, South Carolina, United States
• Center For Oncology Research & Treatment, P.A. — Dallas, Texas, United States
• Mary Crowley Medical Research Center — Dallas, Texas, United States
• Arizona Cancer Center — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.